NCT03316534 (ABC-ASA) is a Phase 2 clinical trial of Aspirin in HIV-infected Patients, sponsored by Azienda Ospedaliera di Perugia.

Who is sponsoring NCT03316534?

NCT03316534 is sponsored by Azienda Ospedaliera di Perugia.

What drugs are being tested in NCT03316534?

Interventions in NCT03316534: Aspirin.

What condition does NCT03316534 study?

NCT03316534 studies HIV-infected Patients.

Is NCT03316534 still recruiting?

NCT03316534 is currently completed. Last updated 20 October 2017.

Last reviewed 2017-10-20 · How we verify

NCT03316534: ABC-ASA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Aspirin on Abacavir-induced Platelet Reactivity in HIV-infected Patients

Completed Phase 2 Last updated 20 October 2017

What this trial tests

Phase 2 trial testing Aspirin in HIV-infected Patients in 40 participants. Completed in 12 October 2017.

Timeline

2 January 2017

Primary endpoint
30 April 2017

12 October 2017

Quick facts

Lead sponsor	Azienda Ospedaliera di Perugia
Phase	Phase 2
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	double
Primary purpose	prevention
Enrollment	40
Start date	2 January 2017
Primary completion	30 April 2017
Estimated completion	12 October 2017

Drugs / interventions tested

Aspirin — full drug profile →

Conditions studied

HIV-infected Patients — all drugs for HIV-infected Patients →

Sponsor

Azienda Ospedaliera di Perugia — full company profile →

Who can join

18 and older, any sex, with HIV-infected Patients. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The specific research questions addressed in the present study are: * to investigate the impact of treatment with low-dose aspirin in HIV-1-infected patients treated with ABC and test it would result in decreased in vivo platelet activation and platelet hyperreactivity * to investigate if aspirin has the same effects in HIV-infected as in HIV-uninfected patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Aspirin

Trials testing the same drug.

NCT07525635 — Aspirin Dosing in Pregnancy · EARLY_PHASE1 · not yet recruiting
NCT07431762 — Comparison of Anti-Thrombotic Treatments Between Aspirin and Warfarin During Initial Six Months After Bioprpsthetic Hear · Phase 4 · not yet recruiting
NCT07373756 — Randomized Controlled Study to Compare Efficacy of Aspirin 75mg and 150mg In the Prevention of Preeclampsia In High Risk · Phase 4 · not yet recruiting
NCT07180472 — Prevention of Stroke Recurrence and Disease Progression in Cerebral Small Vessel Disease With Cilostazol · Phase 4 · not yet recruiting
NCT06638151 — Clopidogrel Plus Aspirin in Acute Ischemic Stroke Following Thrombectomy and/or Intravenous Thrombolysis (CoPrime) · Phase 2 · recruiting

Other Azienda Ospedaliera di Perugia trials

Trials by the same sponsor.

NCT07050940 — Anti PD-1 Plus Postbiotic Versus Anti PD-1 Alone in Locally Advanced or Metastatic, Treatment naïve, Cutaneous Melanoma · NA · recruiting
NCT06458478 — Effects of the Application of a Hyper-oxygenated Gel After Oral Surgery · NA · recruiting
NCT05702554 — Recruitment-to-inflation Ratio to Set Positive End-expiratory Pressure for Laparoscopic/Robotic Surgery: a Multicenter S · unknown
NCT07480187 — Toward Molecular Profiling of Parkinson's Disease in Easily Accessible Biological Matrices · NA · active not recruiting
NCT05125744 — Effect of Positive End Expiratory Pressure on Diaphragmatic Fraction Assessed Through Ultrasound in Intubated Patient Un · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03316534 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Azienda Ospedaliera di Perugia
Last refreshed: 20 October 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03316534.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing